Diezel W, Volk H D, Daniel V, Gruner S, Sönnichsen N
Klinik und Poliklinik für Hautkrankheiten, Humboldt-Universität zu Berlin.
Arch Geschwulstforsch. 1989;59(1):45-51.
A survey is given about the so far known mode of action and the therapeutic application of the following agents with immunostimulatory effects: Interleukin-2, Interferon-gamma, Tumor necrosis factor, Thymosin alpha 1, Thymopentin, Splenopentin, Thymulin, Thymostimulin, Muramyl dipeptide, Bestatin, Tuftsin and Levamisole. The treatment of patients suffering from immunodeficiency disorders and cancer with such agents seems to be possible in the near future.
针对以下具有免疫刺激作用的药物，给出了一份关于其目前已知作用方式和治疗应用的综述：白细胞介素 -2、干扰素 -γ、肿瘤坏死因子、胸腺肽α1、胸腺五肽、脾五肽、胸腺素、胸腺刺激素、胞壁酰二肽、贝他汀、促吞噬素和左旋咪唑。在不久的将来，使用这类药物治疗免疫缺陷疾病和癌症患者似乎是可行的。
